BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 24215716)

  • 1. Evidence for a stimulatory role of high doses of recombinant human follicle-stimulating hormone in the treatment of male-factor infertility.
    Paradisi R; Natali F; Fabbri R; Battaglia C; Seracchioli R; Venturoli S
    Andrologia; 2014; 46(9):1067-72. PubMed ID: 24215716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of high doses of recombinant human follicle-stimulating hormone in the treatment of male factor infertility: results of a pilot study.
    Paradisi R; Busacchi P; Seracchioli R; Porcu E; Venturoli S
    Fertil Steril; 2006 Sep; 86(3):728-31. PubMed ID: 16782097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma concentrations of pituitary and testicular hormones of fertile and infertile men.
    Stanwell-Smith R; Thompson SG; Haines AP; Jeffcoate SL; Hendry WF
    Clin Reprod Fertil; 1985 Mar; 3(1):37-48. PubMed ID: 3919915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant-growth hormone (rec-hGH) therapy in infertile men with idiopathic oligozoospermia.
    Radicioni A; Paris E; Dondero F; Bonifacio V; Isidori A
    Acta Eur Fertil; 1994; 25(5):311-7. PubMed ID: 7660721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of idiopathic oligozoospermia with recombinant human follicle-stimulating hormone: a prospective, randomized, double-blind, placebo-controlled clinical study in Chinese population.
    Ding YM; Zhang XJ; Li JP; Chen SS; Zhang RT; Tan WL; Shi XJ
    Clin Endocrinol (Oxf); 2015 Dec; 83(6):866-71. PubMed ID: 25761129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seminal anti-Müllerian hormone levels during recombinant human follicle-stimulating hormone treatment in men with idiopathic infertility undergoing assisted reproduction cycles.
    Caprio F; De Franciscis P; Trotta C; Ianniello R; Mele D; Colacurci N
    Andrology; 2015 Sep; 3(5):843-7. PubMed ID: 26223208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of hormones on semen parameters in patients with idiopathic or varicocele-related oligoasthenoteratozoospermia (OAT) syndrome.
    Wei TC; Huang WJ; Lin AT; Chen KK
    J Chin Med Assoc; 2013 Nov; 76(11):624-8. PubMed ID: 23933342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of recombinant human follicle-stimulating hormone in the treatment of various types of male-factor infertility at a single university hospital.
    Efesoy O; Cayan S; Akbay E
    J Androl; 2009; 30(6):679-84. PubMed ID: 19478332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FSH dosage effect on conventional sperm parameters: a meta-analysis of randomized controlled studies.
    Cannarella R; La Vignera S; Condorelli RA; Mongioì LM; Calogero AE
    Asian J Androl; 2020; 22(3):309-316. PubMed ID: 31274479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of Vitamin D3 supplementation on Spermatogram and endocrine factors in asthenozoospermia infertile men: a randomized, triple blind, placebo-controlled clinical trial.
    Maghsoumi-Norouzabad L; Zare Javid A; Mansoori A; Dadfar M; Serajian A
    Reprod Biol Endocrinol; 2021 Jul; 19(1):102. PubMed ID: 34225767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of male idiopathic infertility with recombinant human follicle-stimulating hormone: a prospective, controlled, randomized clinical study.
    Foresta C; Bettella A; Garolla A; Ambrosini G; Ferlin A
    Fertil Steril; 2005 Sep; 84(3):654-61. PubMed ID: 16169399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant human FSH reduces sperm DNA fragmentation in men with idiopathic oligoasthenoteratozoospermia.
    Colacurci N; Monti MG; Fornaro F; Izzo G; Izzo P; Trotta C; Mele D; De Franciscis P
    J Androl; 2012; 33(4):588-93. PubMed ID: 21868752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant human follicle stimulating hormone for treatment of male idiopathic infertility: a randomized, double-blind, placebo-controlled, clinical trial.
    Kamischke A; Behre HM; Bergmann M; Simoni M; Schäfer T; Nieschlag E
    Hum Reprod; 1998 Mar; 13(3):596-603. PubMed ID: 9572419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Long-term therapy of oligozoospermia with the aromatase inhibitor testolactone].
    Schill WB; Reiter F; Korting HC; Schweikert HU
    Hautarzt; 1987 Jul; 38(7):395-9. PubMed ID: 3115914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between follicle-stimulating hormone, luteinizing hormone, prolactin, and testosterone with sperm cell concentration and motility.
    Vasquez JM; Ben-Nun I; Greenblatt RB; Mahesh VB; Keel BA
    Obstet Gynecol; 1986 Jan; 67(1):86-90. PubMed ID: 3079622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of recombinant human follicle-stimulating hormone in the treatment of male factor infertility.
    Foresta C; Bettella A; Merico M; Garolla A; Ferlin A; Rossato M
    Fertil Steril; 2002 Feb; 77(2):238-44. PubMed ID: 11821078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone treatment of subfertile males.
    Ovesen P; Jørgensen JO; Ingerslev J; Ho KK; Orskov H; Christiansen JS
    Fertil Steril; 1996 Aug; 66(2):292-8. PubMed ID: 8690119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of mesterolone on sperm count, on serum follicle stimulating hormone, luteinizing hormone, plasma testosterone and outcome in idiopathic oligospermic men.
    Varma TR; Patel RH
    Int J Gynaecol Obstet; 1988 Feb; 26(1):121-8. PubMed ID: 2892728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovarian response to recombinant human follicle-stimulating hormone: a randomized, antimüllerian hormone-stratified, dose-response trial in women undergoing in vitro fertilization/intracytoplasmic sperm injection.
    Arce JC; Andersen AN; Fernández-Sánchez M; Visnova H; Bosch E; García-Velasco JA; Barri P; de Sutter P; Klein BM; Fauser BC
    Fertil Steril; 2014 Dec; 102(6):1633-40.e5. PubMed ID: 25256937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sera gonadotropins, testosterone, and prolactin levels in men with oligozoospermia or asthenozoospermia.
    Check JH; Lurie D; Vetter BH
    Arch Androl; 1995; 35(1):57-61. PubMed ID: 8554433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.